Azienda Ospedaliera Universitaria Integrata Verona
Clinical trials sponsored by Azienda Ospedaliera Universitaria Integrata Verona, explained in plain language.
-
New needle procedure could replace surgery for rare pancreatic tumor
Disease control OngoingThis study compares a newer, less invasive procedure called endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) with standard surgery for treating pancreatic insulinoma, a rare tumor that causes low blood sugar. About 60 adults with small tumors (≤2 cm) will be randoml…
Phase: NA • Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Heart registry tracks 1,000 patients to decode artery risks
Knowledge-focused OngoingThis study looks back at medical records from about 1,000 people who had special tests to check blood flow in their heart arteries. The goal is to see if these test results can help predict future heart attacks or the need for more procedures. Researchers hope this information wi…
Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Knowledge-focused
Last updated May 26, 2026 06:45 UTC
-
New biopsy test may predict pancreatic tumor aggressiveness
Knowledge-focused OngoingThis study involves 100 adults with non-functional pancreatic neuroendocrine tumors. Researchers want to see if checking for two proteins, ATRX and DAXX, in biopsy samples can help predict how aggressive the tumor is. The goal is to improve current methods and better guide treatm…
Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Knowledge-focused
Last updated May 26, 2026 04:37 UTC